InMode INMD
NASDAQ INMD
$14.79 -0.02 (-0.14%)
As of: Sep 9, 2026 · 3:59 PM EDT

InMode (INMD) Non Operating Interest Expenses (2022 - 2023)

InMode's (INMD) quarterly Non Operating Interest Expenses came in at $5.0 million in Q3 2023, up 2520.63% year-over-year from $189000.0 in Q3 2022, and up 2520.63% quarter-over-quarter from $189000.0 in Q3 2022.

Analysis

InMode (INMD) Non Operating Interest Expenses (2022 - 2023) Analysis & Trends

InMode has disclosed Non Operating Interest Expenses across 2 years of filings, most recently posting $5.0 million for Q3 2023.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 351.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 186.00 Mn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 141.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 96.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -53.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 15.80 Mn
10 InMode 955.60 Mn 473.48 Mn 71.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 4.95 Mn
Sep 30, 2022 189,000.00